Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B F Cole

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Biometrics|September 1, 1994
Parametric approaches to quality-adjusted survival analysis. International Breast Cancer Study GroupB F Cole, R D Gelber, K M Anderson
Seminars in Oncology|February 1, 1997
Efficacy, safety, and risk-benefit analysis of adjuvant interferon alfa-2b in melanomaJ M Kirkwood, G D Resnick, B F Cole
AIDS (London, England)|December 31, 1997
gp120-directed antibody-dependent cellular cytotoxicity as a major determinant of the rate of decline in CD4 percentage in HIV-1 diseaseG Skowron, B F Cole, D Zheng, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 1, 1995
The Q-TWiST approach to assessing health-related quality of life in epilepsyC E Schwartz, B F Cole, B G Vickrey, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 3, 1999
Quality of life assessment in the adjuvant setting: is it relevant? International Breast Cancer Study GroupR D Gelber, M Bonetti, B F Cole, et al.
Lancet (London, England)|August 11, 2001
Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysisB F Cole, R D Gelber, S Gelber, et al.
Statistics in Medicine|July 22, 1998
Quality adjusted survival analysis with repeated quality of life measuresP P Glasziou, B F Cole, R D Gelber, et al.
Cancer|March 5, 1998
Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitisM H Friedberg, M J Glantz, M S Klempner, et al.
Archives of Surgery (Chicago, Ill. : 1960)|April 1, 1997
Mutated p53 gene is an independent adverse predictor of survival in colon carcinomaV E Pricolo, S D Finkelstein, K Hansen, et al.
British Journal of Cancer|November 16, 2006
Perinatal factors, growth and development, and osteosarcoma riskR Troisi, M N Masters, K Joshipura, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Biometrics|September 1, 1994
Parametric approaches to quality-adjusted survival analysis. International Breast Cancer Study GroupB F Cole, R D Gelber, K M Anderson
Seminars in Oncology|February 1, 1997
Efficacy, safety, and risk-benefit analysis of adjuvant interferon alfa-2b in melanomaJ M Kirkwood, G D Resnick, B F Cole
AIDS (London, England)|December 31, 1997
gp120-directed antibody-dependent cellular cytotoxicity as a major determinant of the rate of decline in CD4 percentage in HIV-1 diseaseG Skowron, B F Cole, D Zheng, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 1, 1995
The Q-TWiST approach to assessing health-related quality of life in epilepsyC E Schwartz, B F Cole, B G Vickrey, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 3, 1999
Quality of life assessment in the adjuvant setting: is it relevant? International Breast Cancer Study GroupR D Gelber, M Bonetti, B F Cole, et al.
Lancet (London, England)|August 11, 2001
Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysisB F Cole, R D Gelber, S Gelber, et al.
Statistics in Medicine|July 22, 1998
Quality adjusted survival analysis with repeated quality of life measuresP P Glasziou, B F Cole, R D Gelber, et al.
Cancer|March 5, 1998
Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitisM H Friedberg, M J Glantz, M S Klempner, et al.
Archives of Surgery (Chicago, Ill. : 1960)|April 1, 1997
Mutated p53 gene is an independent adverse predictor of survival in colon carcinomaV E Pricolo, S D Finkelstein, K Hansen, et al.
British Journal of Cancer|November 16, 2006
Perinatal factors, growth and development, and osteosarcoma riskR Troisi, M N Masters, K Joshipura, et al.
Pageof 6